Xeltis Hemodialysis Access Graft: aXess Pivotal Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.
Also called NCT05473299
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT05473299
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Belgium, Germany, Greece, Italy, Latvia, Poland, Portugal, Spain, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05473299. Allocation not applicable; no masking; primary purpose treatment. Start 2022-11-04 (actual); primary completion 2025-06-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Xeltis Hemodialysis Access Graft: aXess Pivotal Study
- Condition
- End-stage Renal Disease
- Intervention (Device)
- Xeltis Hemodialysis Access (aXess) graft
- Lead sponsor
- Xeltis
Record details
- Record id
cardio:ct-nct05473299- Content hash
58495f3a45ec495423b72e0723d10f391d45a0ef728903f471532f759b8dc358